COVID-19 is associated with a high incidence of venous thromboembolism, blood clots in the venous circulation, according to a study conducted by researchers at Brighton and Sussex Medical School (BSMS), UK.
A new guide from emergency medicine doctors details the potentially deadly cardiovascular complications COVID-19 can cause.
Ten-year follow-up results of the US Investigational Device Exemption (IDE) Trial of the Melody transcatheter pulmonary valve (TPV) were presented today during the SCAI 2020 Scientific Sessions Virtual Conference. Findings showed favorable outcomes for long-term function, safety, and efficacy for congenital patients who underwent Melody valve implantation within an existing dysfunctional right ventricular outflow tract (RVOT) conduit or bioprosthetic pulmonary valve.
A percutaneous transcatheter therapy for congenital heart disease (CHD) patients with severe pulmonary regurgitation (PR) has been slow to materialize, in comparison to transcatheter pulmonary valve (TPV) therapy for a dysfunctional surgical RV-PA conduit which was first implanted twenty years ago as the Melody TPV. Findings from the Medtronic Harmony TPV Pivotal Trial were presented today during the SCAI 2020 Scientific Sessions Virtual Conference and showed favorable outcomes utilizing the device in patients with severe PR.
In a study published today in Current Biology, Arne Meyer, John O'Keefe and Jasper Poort used a lightweight eye-tracking system composed of miniature video cameras and motion sensors to record head and eye movements in mice without restricting movement or behavior. Measurements were made while the animals performed naturalistic visual behaviors including social interactions with other mice and visual object tracking.
A University of Missouri Health Care neurologist has published more than 40 new recommendations for evaluating and treating stroke patients based on international research examining the link between stroke and novel coronavirus (COVID-19).
A new study shows that when compared with patients without intermediate left main coronary artery disease, those with intermediate left main disease have greater risk of cardiovascular events. The findings of the ISCHEMIA trial sub study were presented during the SCAI 2020 Scientific Sessions Virtual Conference as featured clinical research.
The Society for Cardiovascular Angiography and Interventions (SCAI) has released an expert consensus statement describing recommendations for the management of patients with out-of-hospital cardiac arrest (OHCA). The statement, published today in Catheterization and Cardiovascular Interventions, was presented during the SCAI 2020 Scientific Sessions Virtual Conference.
A novel study sought to reveal whether drug-eluting stents (DES) coated with bioabsorbable polymer (BP) presented a safety advantage without compromising efficacy compared to durable polymer (DP) formulations. Subgroup findings from the TWILIGHT trial were presented today during the SCAI 2020 Scientific Sessions Virtual Conference.
Patients with high lipid levels have an increased risk for ischemic events, despite statin therapy. Findings presented as late-breaking science during the SCAI 2020 Scientific Sessions Virtual Conference revealed that for statin-treated patients with elevated triglycerides and increased cardiovascular risk, icosapent ethyl significantly reduced first and subsequent revascularizations compared with placebo.